Dr. Kelly Butnor
Dr. Kelly Butnor is an assistant professor of pathology at the Vermont Cancer Center.
Phone: (802) 847-8211
Address: 111 Colchester Avenue University of Vermont Burlington, VT 05405
Get Help Contacting This Doctor
Dr. Kelly Butnor is an assistant professor of pathology at the Vermont Cancer Center. She is also involved in clinical research and is an affiliate member of the Vermont Cancer Center. Dr. Butnor’s clinical expertise includes surgical pathology and pulmonary pathology. She is board certified in both anatomical and clinical pathology. Her research primarily revolves around testing novel immunohistochemical markers for the diagnosis of malignant mesothelioma and lung cancer.
Publications
A prolific researcher, Dr. Butnor’s recent publications include the following:
Butnor KJ, Sporn TS, Ordonez NG. Recommendations for the reporting of pleural mesothelioma. Virchows Arch. 2007;450:15-23.
Haegens A, Barrett TF, Gell J, Shukla A, MacPherson M, Vacek P, Poynter ME, Butnor KJ, Janssen-Heininger YM, Steele C, Mossman BT. Airway epithelial NF-kB activation modulates asbestos-induced inflammation and mucin production in vivo. J Immunol 2007;178:1800-1808.
Shulka A, Lounsbury KM, Barrett TF, Gell J, Rincon M, Butnor KJ, Taatjes DJ, Davis GS, Vacek P, Nakayama KI, Nakayama K, Steele C, Mossman BT. Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout mice. Am J Pathol 2007;170:140-51.
Butnor KJ, Sporn TS, Ordonez NG. Recommendations for the reporting of pleural mesothelioma: association of directors of anatomic and surgical pathology. Am J Clin Pathol 2007;127:1-5.
Brooks DG, Butnor KJ, Weinberg DA. Spontaneous orbital hemorrhage in a patient with epithelioid hemangioma. Ophthal Plast Reconstr Surg 2006;487-9.
Butnor KJ, Haque AK, Zander DS, Nicholson AG, Henderson DW, Barrios R, Laga AC, Allen TC, Cermik AH, Killen DE, Cagle PT. Expression of renal cell carcinoma markers EPO, CD10, and RCC marker in malignant mesothelioma and metastatic renal cell carcinoma. Arch Pathol Lab Med 2006;130:823-7.
Butnor KJ, Guinee DG. Pleuropulmonary pathology of Birt-Hogg-Dube syndrome. Am J Surg Pathol 2006;30:395-9.
Poynter ME, Persinger RL, Irvin CG, Butnor KJ, van Hirtum H, Blay W, Heintz NH, Robbins J, Hemenway D, Taatjes DJ, Janssen-Heininger Y. Nitrogen dioxide enhances allergic airway inflammation and hyperresponsiveness in the mouse. Am J Physiol Lung Cell Mol Physiol 2006;290:L144-52.
Butnor KJ, Cooper K. Visceral pleural invasion in lung cancer: recognizing histologic parameters that impact staging and prognosis. Adv Anat Pathol 2005;12:1-6.
Other notable publications she has helped author include the following:
Butnor KJ, Burchette JL, Sporn TA, Hammar SP, Roggli VL. The spectrum of KIT (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single source antibody and a review of the literature. Arch Pathol Lab Med 2004;128:538-543.
O’Neal KD, Butnor KJ, Perkinson KR, Proia AD. Bilateral diffuse uveal melanocytic proliferation associated with pancreatic carcinoma. Survey Ophthal 2003;48:613-625, 2003.
Butnor KJ, Sporn TA, Roggli VL. Exposure to brake dust and malignant mesothelioma: a study of 10 cases with mineral fiber analyses. Ann Occup Hyg 2003;47:325-330.
Roggli VL, Vollmer RT, Butnor KJ, Sporn TA. Tremolite and Mesothelioma. Ann Occup Hyg 2002;46:447-453.
Roggli VL, Sharma A, Butnor KJ, Sporn TA, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathologic correlation of 1445 cases. Ultrastruct Pathol 2002;26:55-65.
Butnor KJ, Sporn TA, Hammar SP, Roggli VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol 2001;25:1304-1309.
Butnor KJ, Sporn TA, Dodd LG. Fine needle aspiration cytology of mucinous cystadenocarcinoma of the lung – report of a case with radiographic and histologic correlation. Acta Cytol 2001;45:779-783.
Additional Work and Distinctions
From 2002 until 2008, Dr. Butnor held the position of assistant professor at the University of Vermont’s Department of Pathology. In 2008, she was promoted to an associate professor of that program, a position she holds to this day. Her other professional and academic honors include the following:
Chief Resident in Pathology, Duke University Medical Center, June 2001 to June 2002 North
Carolina Society of Pathologists Resident Research Award, May 2002 Society for Ultrastructural
Pathology Meritorious Achievement Award, August 2002 Syracuse University Honors Program
Outstanding Undergraduate Thesis Award, May 1993 Phi Beta Kappa, May 1993
Educational Background
Dr. Butnor earned her Bachelor of Science in Biology undergraduate degree in May 1993, graduating from Syracuse University, located in Syracuse, New York, summa cum laude. She then graduated from the Duke University School of Medicine, located in Durham, North Carolina, in May 1997, receiving her Doctor of Medicine degree. She undertook both her residency in pathology and her fellowship in pulmonary pathology with the Duke University Medical Center. She then came to the University of Vermont College of Medicine in 2002.
References:
- University of Vermont
- Vermont Cancer Center
